Five Prime Therapeutics (Five Prime Therapeutics) Sale Of Business : $0.00 Mil (TTM As of Dec. 2020)

View and export this data going back to 2013. Start your Free Trial

What is Five Prime Therapeutics Sale Of Business?

Five Prime Therapeutics's sale of business for the three months ended in Dec. 2020 was $0.00 Mil. It means Five Prime Therapeutics gained $0.00 Mil from selling business. Five Prime Therapeutics's sale of business for the trailing twelve months (TTM) ended in Dec. 2020 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Sep. 2020 ), Five Prime Therapeutics gained the same money from selling business in Dec. 2020 ($0.00 Mil).

Five Prime Therapeutics Sale Of Business Historical Data

The historical data trend for Five Prime Therapeutics's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Five Prime Therapeutics Sale Of Business Chart

Five Prime Therapeutics Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Sale Of Business

Get a 7-Day Free Trial

Five Prime Therapeutics Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
Sale Of Business	Get a 7-Day Free Trial															-	-	-	-	-

Five Prime Therapeutics Sale Of Business Calculation

The amount earned to sell business.

Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Five Prime Therapeutics Sale Of Business Related Terms

Thank you for viewing the detailed overview of Five Prime Therapeutics's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Five Prime Therapeutics (Five Prime Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Five Prime Therapeutics Inc (NAS:FPRX) » Definitions » Sale Of Business

Comparable Companies

Traded in Other Exchanges

N/A

Address

111 Oyster Point Boulevard, South San Francisco, CA, USA, 94080

Website

http://www.fiveprime.com

Five Prime Therapeutics Inc is a biotechnology company focused on discovering and developing protein therapeutics for diseases. The company's product candidates address patient populations for which therapies are still needed. It is focused on advancing its internal pipeline and retaining rights for products in targeted specialty markets. It also seeks to establish additional collaborations to supplement its internal development capabilities. These collaborations generate additional funding in order to further validate the company's technology. It has the following product in the pipeline: Cabiralizumab, FPA150, FPT155, and Bemarituzumab.

Executives

William R Ringo	director
Biotechnology Value Fund L P	10 percent owner	44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bvf Gp Holdings Llc	10 percent owner	44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Ii Gp Llc	other: See Explanation of Responses	44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf I Gp Llc	10 percent owner	44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Partners Os Ltd.	other: See Explanation of Responses	P.O. BOX 309 UGLAND HOUSE, GRAND CAYMAN E9 KY1-1104
Biotechnology Value Trading Fund Os Lp	other: See Explanation of Responses	P.O. BOX 309 UGLAND HOUSE, GRAND CAYMAN E9 KY1-1104
Mark N Lampert	10 percent owner	1 SANSOME ST, 30TH FL, SAN FRANCISCO CA 94104
Biotechnology Value Fund Ii Lp	other: See Explanation of Responses	44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
Bvf Partners L P/il	10 percent owner	44 MONTGOMERY ST., 40TH FLOOR, SAN FRANCISCO CA 94104
Bvf Inc/il	10 percent owner	44 MONTGOMERY STREET, 40TH FL, SAN FRANCISCO CA 94104
David White	officer: See Remarks	4560 HORTON STREET EMERYVILLE CA 94608
Helen Louise Collins	officer: EVP and Chief Medical Officer	TWO CORPORATE DRIVE, SOUTH SAN FRANCISCO CA 94080
Franklin M Berger	director	1000 MARINA BLVD, STE 200, BRISBANE CA 94005
Garry A Nicholson	director	C/O TESARO, INC., 1000 WINTER STREET, SUITE 3300, WALTHAM MA 02451